UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
T QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2013
or
£ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ..... to ..
Commission file number: 001-14669
HELEN OF TROY LIMITED
(Exact name of registrant as specified in its charter)
Bermuda |
|
74-2692550 |
(State or other jurisdiction of |
|
(I.R.S. Employer |
incorporation or organization) |
|
Identification No.) |
|
|
|
Clarenden House Church Street Hamilton, Bermuda |
|
|
(Address of principal executive offices) |
|
|
|
|
|
1 Helen of Troy Plaza |
|
|
El Paso, Texas |
|
79912 |
(Registrants United States Mailing Address) |
|
(Zip Code) |
(915) 225-8000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes T No £
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes T No £
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer T |
|
Accelerated filer £ |
|
|
|
Non-accelerated filer £ (Do not check if a smaller reporting company) |
|
Smaller reporting company £ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes £ No T
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
Class |
|
Outstanding at January 3, 2014 |
Common Shares, $0.10 par value, per share |
|
32,064,062 shares |
HELEN OF TROY LIMITED AND SUBSIDIARIES
HELEN OF TROY LIMITED AND SUBSIDIARIES
Consolidated Condensed Balance Sheets (Unaudited)
(in thousands, except shares and par value)
|
|
November 30, |
|
|
February 28, |
| ||
|
|
2013 |
|
|
2013 |
| ||
|
|
|
|
|
|
| ||
Assets |
|
|
|
|
|
| ||
Assets, current: |
|
|
|
|
|
| ||
Cash and cash equivalents |
|
$ |
28,775 |
|
|
$ |
12,842 |
|
Receivables - principally trade, less allowances of $4,653 and $5,031 |
|
279,699 |
|
|
219,719 |
| ||
Inventory, net |
|
289,890 |
|
|
280,872 |
| ||
Prepaid expenses and other current assets |
|
10,321 |
|
|
8,442 |
| ||
Income taxes receivable |
|
- |
|
|
1,800 |
| ||
Deferred tax assets, net |
|
25,314 |
|
|
21,530 |
| ||
Total assets, current |
|
633,999 |
|
|
545,205 |
| ||
|
|
|
|
|
|
| ||
Property and equipment, net of accumulated depreciation of $74,576 and $74,775 |
|
130,577 |
|
|
101,716 |
| ||
Goodwill |
|
453,241 |
|
|
453,241 |
| ||
Other intangible assets, net of accumulated amortization of $89,504 and $73,344 |
|
327,604 |
|
|
355,628 |
| ||
Deferred tax assets, net |
|
2,780 |
|
|
2,401 |
| ||
Other assets, net of accumulated amortization of $6,214 and $5,403 |
|
10,819 |
|
|
15,813 |
| ||
Total assets |
|
$ |
1,559,020 |
|
|
$ |
1,474,004 |
|
|
|
|
|
|
|
| ||
Liabilities and Stockholders Equity |
|
|
|
|
|
| ||
Liabilities, current: |
|
|
|
|
|
| ||
Revolving line of credit |
|
$ |
4,900 |
|
|
$ |
82,000 |
|
Accounts payable, principally trade |
|
93,322 |
|
|
72,263 |
| ||
Accrued expenses and other current liabilities |
|
158,536 |
|
|
134,063 |
| ||
Income taxes payable |
|
1,261 |
|
|
- |
| ||
Deferred tax liabilities, net |
|
243 |
|
|
339 |
| ||
Long-term debt, current maturities |
|
96,900 |
|
|
20,000 |
| ||
Total liabilities, current |
|
355,162 |
|
|
308,665 |
| ||
|
|
|
|
|
|
| ||
Long-term debt, excluding current maturities |
|
113,609 |
|
|
155,000 |
| ||
Deferred tax liabilities, net |
|
55,880 |
|
|
57,991 |
| ||
Other liabilities, non-current |
|
24,547 |
|
|
25,742 |
| ||
Total liabilities |
|
549,198 |
|
|
547,398 |
| ||
|
|
|
|
|
|
| ||
Commitments and contingencies |
|
|
|
|
|
| ||
|
|
|
|
|
|
| ||
Stockholders equity: |
|
|
|
|
|
| ||
Cumulative preferred stock, non-voting, $1.00 par. Authorized 2,000,000 shares; none issued |
|
- |
|
|
- |
| ||
Common stock, $0.10 par. Authorized 50,000,000 shares; 32,053,272 and 31,868,416 shares issued and outstanding |
|
3,205 |
|
|
3,187 |
| ||
Additional paid in capital |
|
172,766 |
|
|
164,471 |
| ||
Accumulated other comprehensive loss |
|
(1,726 |
) |
|
(2,729 |
) | ||
Retained earnings |
|
835,577 |
|
|
761,677 |
| ||
Total stockholders equity |
|
1,009,822 |
|
|
926,606 |
| ||
Total liabilities and stockholders equity |
|
$ |
1,559,020 |
|
|
$ |
1,474,004 |
|
See accompanying notes to consolidated condensed financial statements.
HELEN OF TROY LIMITED AND SUBSIDIARIES
Consolidated Condensed Statements of Income (Unaudited)
(in thousands, except per share data)
|
|
Three Months Ended November 30, |
|
Nine Months Ended November 30, |
| |||||||||||
|
|
2013 |
|
|
2012 |
|
|
2013 |
|
|
2012 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Sales revenue, net |
|
$ |
380,730 |
|
|
$ |
374,599 |
|
|
$ |
1,004,633 |
|
|
$ |
962,221 |
|
Cost of goods sold |
|
233,029 |
|
|
226,146 |
|
|
613,513 |
|
|
575,590 |
| ||||
Gross profit |
|
147,701 |
|
|
148,453 |
|
|
391,120 |
|
|
386,631 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Selling, general and administrative expense |
|
98,308 |
|
|
101,401 |
|
|
278,697 |
|
|
277,590 |
| ||||
Asset impairment charges |
|
- |
|
|
- |
|
|
12,049 |
|
|
- |
| ||||
Operating income |
|
49,393 |
|
|
47,052 |
|
|
100,374 |
|
|
109,041 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Nonoperating income (expense), net |
|
13 |
|
|
(16 |
) |
|
153 |
|
|
38 |
| ||||
Interest expense |
|
(2,513 |
) |
|
(3,232 |
) |
|
(7,647 |
) |
|
(9,674 |
) | ||||
Income before income taxes |
|
46,893 |
|
|
43,804 |
|
|
92,880 |
|
|
99,405 |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Income tax expense (benefit): |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Current |
|
10,911 |
|
|
11,705 |
|
|
24,780 |
|
|
26,093 |
| ||||
Deferred |
|
(1,542 |
) |
|
(5,620 |
) |
|
(7,133 |
) |
|
(10,847 |
) | ||||
Net income |
|
$ |
37,524 |
|
|
$ |
37,719 |
|
|
$ |
75,233 |
|
|
$ |
84,159 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Basic |
|
$ |
1.17 |
|
|
$ |
1.19 |
|
|
$ |
2.35 |
|
|
$ |
2.65 |
|
Diluted |
|
$ |
1.16 |
|
|
$ |
1.18 |
|
|
$ |
2.33 |
|
|
$ |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Weighted average shares of common stock used in computing net earnings per share: |
|
|
|
|
|
|
|
|
|
|
|
| ||||
Basic |
|
32,047 |
|
|
31,775 |
|
|
31,982 |
|
|
31,739 |
| ||||
Diluted |
|
32,482 |
|
|
31,970 |
|
|
32,311 |
|
|
31,885 |
|
See accompanying notes to consolidated condensed financial statements.
HELEN OF TROY LIMITED AND SUBSIDIARIES
Consolidated Condensed Statements of Comprehensive Income (Unaudited)
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Three Months Ended November 30, |
| ||||||||||||||||||
|
|
2013 |
|
|
|
2012 |
| ||||||||||||||
|
|
Before |
|
|
|
Net of |
|
|
Before |
|
|
|
Net of |
| |||||||
|
|
Tax |
|
Tax |
|
Tax |
|
|
Tax |
|
Tax |
|
Tax |
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Income |
|
$ |
46,893 |
|
$ |
(9,369 |
) |
$ |
37,524 |
|
|
$ |
43,804 |
|
$ |
(6,085 |
) |
$ |
37,719 |
| |
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Cash flow hedge activity - interest rate swaps: |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Changes in fair market value |
|
(70 |
) |
24 |
|
(46 |
) |
|
452 |
|
(158 |
) |
294 |
| |||||||
Interest rate settlements reclassified to income |
|
946 |
|
(330 |
) |
616 |
|
|
1,000 |
|
(350 |
) |
650 |
| |||||||
Subtotal |
|
876 |
|
(306 |
) |
570 |
|
|
1,452 |
|
(508 |
) |
944 |
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Cash flow hedge activity - foreign currency contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Changes in fair market value |
|
(641 |
) |
125 |
|
(516 |
) |
|
(596 |
) |
64 |
|
(532 |
) | |||||||
Ineffectiveness recorded in income |
|
- |
|
- |
|
- |
|
|
93 |
|
(15 |
) |
78 |
| |||||||
Settlements reclassified to income |
|
78 |
|
(15 |
) |
63 |
|
|
350 |
|
(55 |
) |
295 |
| |||||||
Subtotal |
|
(563 |
) |
110 |
|
(453 |
) |
|
(153 |
) |
(6 |
) |
(159 |
) | |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Total other comprehensive income |
|
313 |
|
(196 |
) |
117 |
|
|
1,299 |
|
(514 |
) |
785 |
| |||||||
Comprehensive income |
|
$ |
47,206 |
|
$ |
(9,565 |
) |
$ |
37,641 |
|
|
$ |
45,103 |
|
$ |
(6,599 |
) |
$ |
38,504 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Nine Months Ended November 30, |
| ||||||||||||||||||
|
|
2013 |
|
|
|
2012 |
| ||||||||||||||
|
|
Before |
|
|
|
Net of |
|
|
Before |
|
|
|
Net of |
| |||||||
|
|
Tax |
|
Tax |
|
Tax |
|
|
Tax |
|
Tax |
|
Tax |
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Income |
|
$ |
92,880 |
|
$ |
(17,647 |
) |
$ |
75,233 |
|
|
$ |
99,405 |
|
$ |
(15,246 |
) |
$ |
84,159 |
| |
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Cash flow hedge activity - interest rate swaps: |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Changes in fair market value |
|
(97 |
) |
34 |
|
(63 |
) |
|
(49 |
) |
17 |
|
(32 |
) | |||||||
Interest rate settlements reclassified to income |
|
2,785 |
|
(975 |
) |
1,810 |
|
|
2,906 |
|
(1,017 |
) |
1,889 |
| |||||||
Subtotal |
|
2,688 |
|
(941 |
) |
1,747 |
|
|
2,857 |
|
(1,000 |
) |
1,857 |
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Cash flow hedge activity - foreign currency contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Changes in fair market value |
|
(673 |
) |
136 |
|
(537 |
) |
|
(619 |
) |
73 |
|
(546 |
) | |||||||
Ineffectiveness recorded in income |
|
- |
|
- |
|
- |
|
|
44 |
|
2 |
|
46 |
| |||||||
Settlements reclassified to income |
|
(246 |
) |
39 |
|
(207 |
) |
|
313 |
|
(43 |
) |
270 |
| |||||||
Subtotal |
|
(919 |
) |
175 |
|
(744 |
) |
|
(262 |
) |
32 |
|
(230 |
) | |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Total other comprehensive income |
|
1,769 |
|
(766 |
) |
1,003 |
|
|
2,595 |
|
(968 |
) |
1,627 |
| |||||||
Comprehensive income |
|
$ |
94,649 |
|
$ |
(18,413 |
) |
$ |
76,236 |
|
|
$ |
102,000 |
|
$ |
(16,214 |
) |
$ |
85,786 |
| |
See accompanying notes to consolidated condensed financial statements.
HELEN OF TROY LIMITED AND SUBSIDIARIES
Consolidated Condensed Statements of Cash Flows (Unaudited)
(in thousands)
|
|
Nine Months Ended November 30, |
| |||||
|
|
2013 |
|
|
2012 |
| ||
|
|
|
|
|
|
| ||
Cash provided (used) by operating activities: |
|
|
|
|
|
| ||
Net income |
|
$ |
75,233 |
|
|
$ |
84,159 |
|
Adjustments to reconcile net income to net cash provided by operating activities |
|
|
|
|
|
| ||
Depreciation and amortization |
|
25,861 |
|
|
26,591 |
| ||
Provision for doubtful receivables |
|
744 |
|
|
114 |
| ||
Non-cash share-based compensation |
|
9,200 |
|
|
4,417 |
| ||
Intangible asset impairment charges |
|
12,049 |
|
|
- |
| ||
(Gain) loss on the sale of property and equipment |
|
74 |
|
|
43 |
| ||
Deferred income taxes and tax credits |
|
(7,136 |
) |
|
(10,906 |
) | ||
Changes in operating capital: |
|
|
|
|
|
| ||
Receivables |
|
(60,724 |
) |
|
(62,955 |
) | ||
Inventories |
|
(9,018 |
) |
|
(60,052 |
) | ||
Prepaid expenses and other current assets |
|
955 |
|
|
(512 |
) | ||
Other assets and liabilities, net |
|
(1,340 |
) |
|
(469 |
) | ||
Accounts payable |
|
21,478 |
|
|
16,414 |
| ||
Accrued expenses and other current liabilities |
|
22,787 |
|
|
20,574 |
| ||
Accrued income taxes |
|
949 |
|
|
6,909 |
| ||
Net cash provided by operating activities |
|
91,112 |
|
|
24,327 |
| ||
|
|
|
|
|
|
| ||
Cash provided (used) by investing activities: |
|
|
|
|
|
| ||
Capital and intangible asset expenditures |
|
(38,563 |
) |
|
(6,405 |
) | ||
Proceeds from the sale or disposal of property and equipment |
|
- |
|
|
26 |
| ||
Note receivable from land sale |
|
- |
|
|
737 |
| ||
Net cash used by investing activities |
|
(38,563 |
) |
|
(5,642 |
) | ||
|
|
|
|
|
|
| ||
Cash provided (used) by financing activities: |
|
|
|
|
|
| ||
Proceeds from line of credit |
|
107,300 |
|
|
184,950 |
| ||
Repayment of line of credit |
|
(184,400 |
) |
|
(212,650 |
) | ||
Proceeds (repayments) of long-term debt |
|
35,509 |
|
|
(3,000 |
) | ||
Payments of financing costs |
|
(127 |
) |
|
(28 |
) | ||
Proceeds from share issuances under share-based compensation plans, including tax benefits |
|
5,019 |
|
|
7,525 |
| ||
Payment of tax obligations resulting from issuance of restricted shares |
|
(483 |
) |
|
(108 |
) | ||
Payments for repurchases of common stock |
|
(1,311 |
) |
|
(1,759 |
) | ||
Share-based compensation tax benefit |
|
1,877 |
|
|
661 |
| ||
Net cash used by financing activities |
|
(36,616 |
) |
|
(24,409 |
) | ||
|
|
|
|
|
|
| ||
Net increase (decrease) in cash and cash equivalents |
|
15,933 |
|
|
(5,724 |
) | ||
Cash and cash equivalents, beginning balance |
|
12,842 |
|
|
21,846 |
| ||
Cash and cash equivalents, ending balance |
|
$ |
28,775 |
|
|
$ |
16,122 |
|
See accompanying notes to consolidated condensed financial statements.
HELEN OF TROY LIMITED AND SUBSIDIARIES
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS (Unaudited)
November 30, 2013
Note 1 - Basis of Presentation and Conventions Used in this Report
The accompanying consolidated condensed financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly our consolidated financial position as of November 30, 2013 and February 28, 2013, and the results of our consolidated operations for the three- and nine-month periods ended November 30, 2013 and 2012. We follow the same accounting policies when preparing quarterly financial data as we use for preparing annual data. These statements should be read in conjunction with the consolidated financial statements and the notes included in our latest annual report on Form 10-K for the fiscal year ended February 28, 2013, and our other reports on file with the Securities and Exchange Commission (SEC).
In this report and the accompanying consolidated condensed financial statements and notes, unless the context suggests otherwise or otherwise indicated, references to the Company, our Company, Helen of Troy, we, us, or our refer to Helen of Troy Limited and its subsidiaries, and amounts are expressed in thousands of U.S. Dollars. We refer to the Companys common shares, par value $0.10 per share, as common stock. References to Kaz refer to the operations of Kaz, Inc. and its subsidiaries. References to PUR refer to the PUR brand of water filtration products that we acquired, along with certain other assets and liabilities, from The Procter & Gamble Company and certain of its affiliates. Kaz and PUR comprise a segment within the Company referred to as the Healthcare / Home Environment segment. References to OXO refer to the operations of OXO International and certain of its affiliated subsidiaries that comprise our Housewares segment. Product and service names mentioned in this report are used for identification purposes only and may be protected by trademarks, trade names, services marks, and/or other intellectual property rights of the Company and/or other parties in the United States and/or other jurisdictions. The absence of a specific attribution in connection with any such mark does not constitute a waiver of any such right. All trademarks, trade names, service marks, and logos referenced herein belong to their owners. References to the FASB refer to the Financial Accounting Standards Board. References to GAAP refer to U.S. generally accepted accounting principles. References to ASC refer to the codification of GAAP in the Accounting Standards Codification issued by the FASB.
We are a global designer, developer, importer, marketer, and distributor of an expanding portfolio of brand-name consumer products. We have three segments: Housewares, Healthcare / Home Environment and Personal Care. Our Housewares segment provides a broad range of innovative consumer products for the home. Product offerings include food preparation and storage, cleaning, organization, and baby and toddler care products. The Healthcare / Home Environment segment focuses on health care devices such as thermometers, blood pressure monitors, humidifiers, and heating pads; water filtration systems; and small home appliances such as air purifiers, portable heaters, fans, and insect control devices (bug zappers). Our Personal Care segments products include electric hair care, beauty care and wellness appliances; grooming tools and accessories; and liquid, solid- and powder-based personal care and grooming products. All three segments sell their products primarily through mass merchandisers, drugstore chains, warehouse clubs, catalogs, grocery stores, and specialty stores. In addition, the Healthcare / Home Environment segment sells certain of its product lines through medical distributors and other products through home improvement stores, and the Personal Care segment sells extensively through beauty supply retailers and wholesalers. Our business is seasonal due to different calendar events, holidays, and seasonal weather patterns. Historically, our highest sales volume and operating income occur in our third fiscal quarter ending November 30th. We purchase our products from unaffiliated manufacturers, most of which are located in China, Mexico and the United States.
Our consolidated condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the disclosure of contingent assets and liabilities. Actual results could differ from those estimates. We have reclassified, combined or separately disclosed certain amounts in the prior periods consolidated condensed financial statements and accompanying footnotes to conform to the current periods presentation.
Note 2 New Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the FASB or other standards setting bodies that we adopt according to the various timetables the FASB specifies. Unless otherwise discussed, we believe the impact of recently issued standards that are not yet effective will not have a material impact on our consolidated financial position, results of operations and cash flows upon adoption.
Note 3 Commitments and Contingencies
We are involved in various legal claims and proceedings in the normal course of operations. We believe the outcome of these matters will not have a material adverse effect on our consolidated financial position, results of operations or liquidity.
Notes 7, 9, 11, 12, and 14 provide additional information regarding certain of our significant commitments and certain significant contingencies we have provided for in the accompanying consolidated condensed financial statements.
Our products are under warranty against defects in material and workmanship for periods ranging from two to five years. We estimate our warranty accrual using historical trends and believe that these trends are the most reliable method by which we can estimate our warranty liability. The following table summarizes the activity in our warranty accrual for the periods covered in the accompanying consolidated condensed statements of income:
ACCRUAL FOR WARRANTY RETURNS
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended November 30, |
|
Nine Months Ended November 30, |
| |||||||||||||
|
|
|
2013 |
|
|
2012 |
|
|
|
2013 |
|
|
2012 |
| ||||
Beginning balance |
|
|
$ |
21,357 |
|
|
$ |
21,860 |
|
|
$ |
23,150 |
|
|
$ |
26,665 |
| |
Additions to the accrual |
|
|
6,504 |
|
|
11,027 |
|
|
25,280 |
|
|
25,800 |
| |||||
Reductions of the accrual - payments and credits issued |
|
|
(5,770 |
) |
|
(7,496) |
|
|
(26,339 |
) |
|
(27,074 |
) | |||||
Ending balance |
|
|
$ |
22,091 |
|
|
$ |
25,391 |
|
|
$ |
22,091 |
|
|
$ |
25,391 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 4 Earnings per Share
We compute basic earnings per share using the weighted average number of shares of common stock outstanding during the period and diluted earnings per share using basic earnings per share plus the effect of dilutive securities. Our securities that can have dilutive effects consist of outstanding options to purchase common stock and issued and contingently issuable unvested restricted share units and awards. See Note 14 to these consolidated condensed financial statements for more information regarding these restricted share units and awards. Options for common stock are excluded from the computation of diluted earnings per share if their effect is antidilutive.
For the periods covered in the accompanying consolidated condensed statements of income, the basic and diluted shares are as follows:
WEIGHTED AVERAGE DILUTED SECURITIES
(in thousands)
|
|
Three Months Ended November 30, |
|
Nine Months Ended November 30, |
| |||||||||
|
|
|
2013 |
|
|
2012 |
|
|
|
2013 |
|
|
2012 |
|
Weighted average shares outstanding, basic |
|
|
32,047 |
|
|
31,775 |
|
|
31,982 |
|
|
31,739 |
| |
Incremental shares from share-based payment arrangements |
|
|
435 |
|
|
195 |
|
|
329 |
|
|
146 |
| |
Weighted average shares outstanding, diluted |
|
|
32,482 |
|
|
31,970 |
|
|
32,311 |
|
|
31,885 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Dilutive securities, as a result of in-the-money options |
|
|
574 |
|
|
354 |
|
|
373 |
|
|
348 |
| |
Dilutive securities, as a result of unvested restricted shares |
|
|
408 |
|
|
143 |
|
|
298 |
|
|
143 |
| |
Antidilutive securities, as a result of out-of-the-money options |
|
|
358 |
|
|
612 |
|
|
586 |
|
|
618 |
| |
Note 5 Segment Information
The following tables contain segment information for the periods covered in the accompanying consolidated condensed statements of income:
THREE MONTHS ENDED NOVEMBER 30, 2013 AND 2012
(in thousands)
|
|
|
|
Healthcare / |
|
Personal |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
November 30, 2013 |
|
Housewares |
|
Home Environment |
|
Care |
|
Total |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Sales revenue, net |
|
$ |
74,776 |
|
$ |
165,752 |
|
$ |
140,202 |
|
$ |
380,730 |
|
Asset impairment charges |
|
- |
|
- |
|
- |
|
- |
| ||||
Operating income |
|
15,278 |
|
10,665 |
|
23,450 |
|
49,393 |
| ||||
Capital and intangible asset expenditures |
|
193 |
|
3,207 |
|
585 |
|
3,985 |
| ||||
Depreciation and amortization |
|
897 |
|
5,349 |
|
2,726 |
|
8,972 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
Healthcare / |
|
Personal |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
November 30, 2012 |
|
Housewares |
|
Home Environment |
|
Care |
|
Total |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Sales revenue, net |
|
$ |
67,787 |
|
$ |
158,174 |
|
$ |
148,638 |
|
$ |
374,599 |
|
Operating income |
|
13,927 |
|
11,323 |
|
21,802 |
|
47,052 |
| ||||
Capital and intangible asset expenditures |
|
118 |
|
230 |
|
297 |
|
645 |
| ||||
Depreciation and amortization |
|
1,177 |
|
4,376 |
|
3,243 |
|
8,796 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
NINE MONTHS ENDED NOVEMBER 30, 2013 AND 2012 |
|
|
|
|
| ||||||||
(in thousands) |
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
Healthcare / |
|
Personal |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
November 30, 2013 |
|
Housewares |
|
Home Environment |
|
Care |
|
Total |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Sales revenue, net |
|
$ |
208,471 |
|
$ |
424,398 |
|
$ |
371,764 |
|
$ |
1,004,633 |
|
Asset impairment charges |
|
- |
|
- |
|
12,049 |
|
12,049 |
| ||||
Operating income |
|
41,506 |
|
22,175 |
|
36,693 |
|
100,374 |
| ||||
Capital and intangible asset expenditures |
|
574 |
|
36,321 |
|
1,668 |
|
38,563 |
| ||||
Depreciation and amortization |
|
2,946 |
|
14,897 |
|
8,018 |
|
25,861 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
Healthcare / |
|
Personal |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
November 30, 2012 |
|
Housewares |
|
Home Environment |
|
Care |
|
Total |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Sales revenue, net |
|
$ |
192,606 |
|
$ |
391,061 |
|
$ |
378,554 |
|
$ |
962,221 |
|
Operating income |
|
37,282 |
|
26,197 |
|
45,562 |
|
109,041 |
| ||||
Capital and intangible asset expenditures |
|
635 |
|
2,354 |
|
3,416 |
|
6,405 |
| ||||
Depreciation and amortization |
|
3,753 |
|
13,086 |
|
9,752 |
|
26,591 |
|
We compute operating income for each segment based on net sales revenue, less cost of goods sold, selling, general and administrative expense (SG&A), and any asset impairment charges associated with the segment. The SG&A used to compute each segments operating income is directly associated with the segment, plus overhead expenses that are allocable to the segment. We make allocations of overhead between operating segments using a number of relevant allocation criteria, depending on the nature of the expense, the most significant of which are relative revenues, estimates of relative labor expenditures, headcount, and facility square footage. We do not allocate nonoperating income and expense, including interest or income taxes to operating segments.
Note 6 Comprehensive Loss
The components of accumulated other comprehensive loss, net of tax, are as follows:
COMPONENTS OF ACCUMULATED OTHER COMPREHENSIVE LOSS
(in thousands)
|
|
|
November 30, |
|
|
February 28, |
| ||
|
|
|
2013 |
|
|
2013 |
| ||
|
|
|
|
|
|
|
| ||
Unrealized holding losses on cash flow hedges - interest rate swap, net of tax (1) |
|
|
$ |
(1,388 |
) |
|
$ |
(3,135 |
) |
Unrealized holding gains (losses) on cash flow hedges - foreign currency contracts, net of tax (2) |
|
|
(338 |
) |
|
406 |
| ||
Total accumulated other comprehensive loss |
|
|
$ |
(1,726 |
) |
|
$ |
(2,729 |
) |
(1) Includes net deferred tax benefits of $0.75 and $1.69 million at November 30, 2013 and February 28, 2013, respectively.
(2) Includes net deferred tax benefits (expense) of $0.09 and ($0.09) million at November 30, 2013 and February 28, 2013, respectively.
Note 7 Supplemental Balance Sheet Information
PROPERTY AND EQUIPMENT
(in thousands)
|
|
Estimated |
|
|
|
|
|
|
| ||
|
|
Useful Lives |
|
|
November 30, |
|
|
February 28, |
| ||
|
|
(Years) |
|
|
2013 |
|
|
2013 |
| ||
Land |
|
- |
|
|
$ |
12,800 |
|
|
$ |
12,800 |
|
Building and improvements |
|
3 - 40 |
|
|
98,469 |
|
|
66,994 |
| ||
Computer, furniture and other equipment |
|
3 - 15 |
|
|
60,002 |
|
|
58,284 |
| ||
Tools, molds and other production equipment |
|
1 - 10 |
|
|
28,738 |
|
|
29,264 |
| ||
Construction in progress |
|
- |
|
|
5,144 |
|
|
9,149 |
| ||
Property and equipment, gross |
|
|
|
|
205,153 |
|
|
176,491 |
| ||
Less accumulated depreciation |
|
|
|
|
(74,576 |
) |
|
(74,775 |
) | ||
Property and equipment, net |
|
|
|
|
$ |
130,577 |
|
|
$ |
101,716 |
|
Property and equipment includes cumulative capital expenditures of $35.22 and $4.03 million as of November 30, 2013 and February 28, 2013, respectively, in connection with our new 1.3 million square foot distribution facility on approximately 84 acres of land in Olive Branch, Mississippi. The new facility will consolidate the operations of our U.S. based Personal Care and Healthcare / Home Environment appliance businesses. The new facility became operational for the Healthcare / Home Environment segment during the first week of September 2013. We expect to complete the transition of our domestic Personal Care appliance distribution to the new facility in the first quarter of fiscal year 2015. Remaining capital expenditure commitments in connection with the Personal Care appliance move are not expected to be material. See Note 9 to these consolidated condensed financial statements for related information regarding the debt incurred to fund the construction of the new distribution facility.
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
(in thousands)
|
|
|
November 30, |
|
|
February 28, |
| ||
|
|
|
2013 |
|
|
2013 |
| ||
Accrued compensation, benefits and payroll taxes |
|
|
$ |
44,478 |
|
|
$ |
34,265 |
|
Accrued sales returns, discounts and allowances |
|
|
35,096 |
|
|
22,561 |
| ||
Accrued warranty returns |
|
|
22,091 |
|
|
23,150 |
| ||
Accrued advertising |
|
|
23,561 |
|
|
14,554 |
| ||
Accrued product liability, legal and professional fees |
|
|
6,384 |
|
|
9,061 |
| ||
Accrued royalties |
|
|
7,639 |
|
|
7,731 |
| ||
Accrued property, sales and other taxes |
|
|
8,083 |
|
|
5,729 |
| ||
Derivative liabilities, current |
|
|
2,559 |
|
|
3,044 |
| ||
Other |
|
|
8,645 |
|
|
13,968 |
| ||
Total accrued expenses and other current liabilities |
|
|
$ |
158,536 |
|
|
$ |
134,063 |
|
OTHER LIABILITIES, NON-CURRENT
(in thousands)
|
|
|
November 30, |
|
|
February 28, |
| ||
|
|
|
2013 |
|
|
2013 |
| ||
|
|
|
|
|
|
|
| ||
Deferred compensation liability |
|
|
$ |
7,908 |
|
|
$ |
6,443 |
|
Liability for uncertain tax positions |
|
|
15,524 |
|
|
15,759 |
| ||
Derivative liabilities |
|
|
- |
|
|
1,780 |
| ||
Other liabilites |
|
|
1,115 |
|
|
1,760 |
| ||
Total other liabilities, non-current |
|
|
$ |
24,547 |
|
|
$ |
25,742 |
|
Note 8 Goodwill and Intangible Assets
Annual Impairment Testing in the First Quarter of Fiscal Year 2014 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2014. As a result of our testing of indefinite-lived trademarks and licenses, we recorded a non-cash asset impairment charge of $12.05 million ($12.03 million after tax). The charge was related to certain trademarks in our Personal Care segment, which were written down to their estimated fair value, determined on the basis of future discounted cash flows using the relief from royalty valuation method.
Annual Impairment Testing in the First Quarter of Fiscal Year 2013 - We performed our annual evaluation of goodwill and indefinite-lived intangible assets for impairment during the first quarter of fiscal year 2013. As a result, we concluded no asset impairment charges were required. For fiscal year 2013, the estimated fair value of the indefinite-lived trademarks and licenses, reporting unit net assets and the Companys estimated enterprise value exceeded their respective carrying values as of the date of the evaluation.
A summary of the carrying amounts and associated accumulated amortization for all intangible assets by operating segment follows:
GOODWILL AND INTANGIBLE ASSETS
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, 2013 |
|
|
February 28, 2013 |
| ||||||||||||||||||||
|
|
Gross |
|
Cumulative |
|
|
|
|
|
|
Gross |
|
Cumulative |
|
|
|
|
| ||||||||
|
|
Carrying |
|
Goodwill |
|
Accumulated |
|
Net Book |
|
|
Carrying |
|
Goodwill |
|
Accumulated |
|
Net Book |
| ||||||||
Description |
|
Amount |
|
Impairments |
|
Amortization |
|
Value |
|
|
Amount |
|
Impairments |
|
Amortization |
|
Value |
| ||||||||
Housewares: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Goodwill |
|
$ |
166,132 |
|
$ |
- |
|
$ |
- |
|
$ |
166,132 |
|
|
$ |
166,132 |
|
$ |
- |
|
$ |
- |
|
$ |
166,132 |
|
Trademarks - indefinite |
|
75,200 |
|
- |
|
- |
|
75,200 |
|
|
75,200 |
|
- |
|
- |
|
75,200 |
| ||||||||
Other intangibles - finite |
|
15,794 |
|
- |
|
(10,950 |
) |
4,844 |
|
|
15,609 |
|
- |
|
(10,070 |
) |
5,539 |
| ||||||||
Total Housewares |
|
257,126 |
|
- |
|
(10,950 |
) |
246,176 |
|
|
256,941 |
|
- |
|
(10,070 |
) |
246,871 |
| ||||||||
Healthcare / Home Environment: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Goodwill |
|
251,758 |
|
- |
|
- |
|
251,758 |
|
|
251,758 |
|
- |
|
- |
|
251,758 |
| ||||||||
Trademarks - indefinite |
|
54,000 |
|
- |
|
- |
|
54,000 |
|
|
54,000 |
|
- |
|
- |
|
54,000 |
| ||||||||
Licenses - finite |
|
15,300 |
|
- |
|
(5,676 |
) |
9,624 |
|
|
15,300 |
|
- |
|
(3,455 |
) |
11,845 |
| ||||||||
Other Intangibles - finite |
|
114,490 |
|
- |
|
(31,833 |
) |
82,657 |
|
|
114,490 |
|
- |
|
(23,220 |
) |
91,270 |
| ||||||||
Total Healthcare / Home Environment |
|
435,548 |
|
- |
|
(37,509 |
) |
398,039 |
|
|
435,548 |
|
- |
|
(26,675 |
) |
408,873 |
| ||||||||
Personal Care: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Goodwill |
|
81,841 |
|
(46,490 |
) |
- |
|
35,351 |
|
|
81,841 |
|
(46,490 |
) |
- |
|
35,351 |
| ||||||||
Trademarks - indefinite |
|
63,754 |
|
- |
|
- |
|
63,754 |
|
|
75,803 |
|
- |
|
- |
|
75,803 |
| ||||||||
Trademarks - finite |
|
150 |
|
- |
|
(76 |
) |
74 |
|
|
150 |
|
- |
|
(72 |
) |
78 |
| ||||||||
Licenses - indefinite |
|
10,300 |
|
- |
|
- |
|
10,300 |
|
|
10,300 |
|
- |
|
- |
|
10,300 |
| ||||||||
Licenses - finite |
|
18,683 |
|
- |
|
(15,807 |
) |
2,876 |
|
|
18,683 |
|
- |
|
(15,570 |
) |
3,113 |
| ||||||||
Other intangibles - finite |
|
49,437 |
|
- |
|
(25,162 |
) |
24,275 |
|
|
49,437 |
|
- |
|
(20,957 |
) |
28,480 |
| ||||||||
Total Personal Care |
|
224,165 |
|
(46,490 |
) |
(41,045 |
) |
136,630 |
|
|
236,214 |
|
(46,490 |
) |
(36,599 |
) |
153,125 |
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
Total |
|
$ |
916,839 |
|
$ |
(46,490 |
) |
$ |
(89,504 |
) |
$ |
780,845 |
|
|
$ |
928,703 |
|
$ |
(46,490 |
) |
$ |
(73,344 |
) |
$ |
808,869 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table summarizes the amortization expense attributable to intangible assets for the periods covered in the accompanying consolidated condensed statements of income, as well as our estimated amortization expense for the fiscal years 2014 through 2019.
AMORTIZATION OF INTANGIBLE ASSETS
(in thousands)
Aggregate Amortization Expense |
|
|
| |
For the three months ended |
|
|
| |
|
|
|
| |
November 30, 2013 |
|
$ |
5,407 |
|
November 30, 2012 |
|
$ |
5,538 |
|
Aggregate Amortization Expense |
|
|
| |
For the nine months ended |
|
|
| |
|
|
|
| |
November 30, 2013 |
|
$ |
16,246 |
|
November 30, 2012 |
|
$ |
16,800 |
|
Estimated Amortization Expense |
|
|
|
| |
For the fiscal years ended |
|
|
|
| |
|
|
|
|
|
|
February 2014 |
|
|
$ |
21,556 |
|
February 2015 |
|
|
$ |
21,030 |
|
February 2016 |
|
|
$ |
20,847 |
|
February 2017 |
|
|
$ |
20,523 |
|
February 2018 |
|
|
$ |
16,703 |
|
February 2019 |
|
|
$ |
11,962 |
|
Note 9 Debt
Revolving Line of Credit - We have a Credit Agreement (the Credit Agreement) with Bank of America, N.A. that provides for an unsecured total revolving commitment of up to $250.00 million. The commitment under the Credit Agreement terminates on December 30, 2015. Borrowings accrue interest under one of two alternative methods as described in the Credit Agreement. With each borrowing against our credit line, we can elect the interest rate method based on our funding needs at the time. We also incur loan commitment fees and letter of credit fees under the Credit Agreement. Outstanding letters of credit reduce the borrowing availability under the Credit Agreement on a dollar-for-dollar basis. As of November 30, 2013, the outstanding revolving loan principal balance was $4.90 million and there were $0.28 million of open letters of credit outstanding against the Credit Agreement. For the three- and nine-months ended November 30, 2013, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.17 to 3.25 percent and 1.17 to 3.63 percent, respectively. For both the three- and nine-months ended November 30, 2012, borrowings under the Credit Agreement incurred interest charges at rates ranging from 1.59 to 4.00 percent. As of November 30, 2013, the amount available for borrowings under the Credit Agreement was $244.82 million.
Long-Term Debt A summary of our long-term debt is as follows:
LONG-TERM DEBT
(dollars in thousands)
|
|
Original |
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
|
Date |
|
|
Interest |
|
|
|
|
|
November 30, |
|
|
February 28, |
| ||
|
|
Borrowed |
|
|
Rates |
|
|
Matures |
|
|
2013 |
|
|
2013 |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
$38 million unsecured loan with a state industrial development corporation, interim draws, interest is set and payable quarterly at the Base Rate, as defined below, plus a margin of up to 1.125%, or applicable LIBOR plus a margin of up to 2.125%, as determined by the interest rate elected. Loan subject to holders call on or after March 1, 2018. Loan can be prepaid without penalty any |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
time after March 20, 2014. |
|
03/13 |
|
|
1.17% |
|
|
03/23 |
|
|
$ |
35,509 |
|
|
$ |
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
$75 million unsecured floating interest rate 10 year Senior Notes. Interest set and payable quarterly at three-month LIBOR plus 90 basis points. Principal is due in June 2014. Notes can be prepaid without penalty. (1) |
|
06/04 |
|
|
6.01% |
|
|
06/14 |
|
|
75,000 |
|
|
75,000 |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
$100 million unsecured Senior Notes payable at a fixed interest rate of 3.90%. Interest payable semi-annually. Annual principal payments of $20 million begin in January 2014. Prepayment of notes are subject to a make whole premium. |
|
01/11 |
|
|
3.90% |
|
|
01/18 |
|
|
100,000 |
|
|
100,000 |
| ||
Total long-term debt |
|
|
|
|
|
|
|
|
|
|
210,509 |
|
|
175,000 |
| ||
Less current maturities of long-term debt |
|
|
|
|
|
|
|
|
|
|
(96,900 |
) |
|
(20,000 |
) | ||
Long-term debt, excluding current maturities |
|
|
|
|
|
|
|
|
|
|
$ |
113,609 |
|
|
$ |
155,000 |
|
(1) Floating interest rates have been hedged with an interest rate swap to effectively fix interest rates. Additional information regarding the swap is provided in Note 12 to these consolidated condensed financial statements.
In March 2013, Kaz USA, Inc. (Kaz USA), a wholly owned subsidiary of the Company, entered into a Loan Agreement, dated as of March 1, 2013, with the Mississippi Business Finance Corporation (the MBFC) in connection with the issuance by the MBFC of up to $38.00 million of taxable industrial development revenue bonds (the Bonds). The Bonds are issued under a Trust Indenture (the IRB Indenture), between the MBFC and Deutsche Bank National Trust Company, as trustee. Interim draws, accumulating up to a $38.00 million aggregate maximum, may be made through March 20, 2014. The Bonds and the related loan to Kaz USA (the MBFC Loan) will bear interest at a variable rate as elected by Kaz USA equal to either (a) a Base Rate plus a margin of 0.00 to 1.125 percent, depending upon the leverage ratio at the time of the borrowing or (b) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 to 2.125 percent, depending upon the leverage ratio at the time of the borrowing. The Base Rate is equal to the highest of (i) the federal funds rate for the day, plus 0.50 percent, (ii) the prime rate of Bank of America, N.A., or (iii) the respective one-, two-, three-, or six-month LIBOR rate plus 1.00 percent. The proceeds of the MBFC Loan have been used by Kaz USA to finance the purchase of land, construction of a distribution facility and the acquisition and installation of equipment, machinery and related assets located in Olive Branch, Mississippi.
Assuming the $38.00 million aggregate maximum is borrowed, outstanding principal of the MBFC Loan will be payable as follows: $1.90 million on March 1 in each of 2014, 2015, 2018, 2019, 2020, 2021 and 2022; $3.80 million on March 1, 2016; $5.70 million on March 1, 2017; and $15.20 million on March 1, 2023. Any remaining outstanding principal and interest is due upon maturity on March 1, 2023. The MBFC Loan may be prepaid in whole or part without penalty any time after March 20, 2014. Additionally, Bank of America, N.A., the purchaser of the Bonds, may elect for the MBFC Loan to be prepaid in full on March 1, 2018. Following March 1, 2018, Bank of America, N.A. may elect for the MBFC Loan to be prepaid on March 1 of each subsequent year prior to maturity upon at least 90 days notice. In lieu of any prepayment, the Bonds may be purchased by a transferee, as permitted under the IRB Indenture.
The fair market value of the fixed rate debt at November 30, 2013, computed using a discounted cash flow analysis, was $104.96 million compared to the $100.00 million book value and represents a Level 2 liability. All other long-term debt has floating interest rates, and its book value approximates its fair value at November 30, 2013.
All of our debt is unconditionally guaranteed, on a joint and several basis, by the Company and certain of its subsidiaries. Our debt agreements require the maintenance of certain financial covenants, including maximum leverage ratios, minimum interest coverage ratios and minimum consolidated net worth levels (as each of these terms is defined in the various agreements). Our debt agreements also contain other customary covenants, including, among other things, covenants restricting or limiting the Company, except under certain conditions set forth therein, from (1) incurring debt, (2) incurring liens on its properties, (3) making certain types of investments, (4) selling certain assets or making other fundamental changes relating to mergers and consolidations, and (5) repurchasing shares of our common stock and paying dividends.
As of November 30, 2013, our debt agreements effectively limited our ability to incur more than $376.58 million of additional debt from all sources, including draws on the Credit Agreement. As of November 30, 2013, we were in compliance with the terms of all of our debt agreements.
Note 10 Income Taxes
Income tax expense for the three- and nine-month periods ended November 30, 2013 was 20.0 and 19.0 percent of income before income taxes, respectively, compared to 13.9 and 15.3 percent, respectively, for the same periods last year. The year-over-year comparison of our effective tax rate for the quarter was impacted by discrete items that were a benefit to tax expense in the third quarter of the prior fiscal year, and shifts in the mix of taxable income between our various tax jurisdictions. Our effective tax rate for the nine months ended November 30, 2013 was also impacted by asset impairment charges of $12.05 million recorded in the first quarter of fiscal year 2014, for which the related tax benefit was only $0.02 million.
Note 11 Fair Value
The fair value hierarchy of our financial assets and liabilities carried at fair value and measured on a recurring basis is as follows:
FAIR VALUES OF FINANCIAL ASSETS AND LIABILITIES
(in thousands)
|
|
|
|
|
Quoted Prices in |
|
Significant Other |
| |||
|
|
|
|
|
Active Markets |
|
Observable |
| |||
|
|
|
Fair Values at |
|
for Identical Assets |
|
Market Inputs |
| |||
Description |
|
|
November 30, 2013 |
< |